Drug Type CAR-T |
Synonyms LQ 102, LQ-102 |
Target |
Action inhibitors |
Mechanism GPC3 inhibitors(Glypican-3 inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
GPC3 Positive Hepatocellular Carcinoma | Preclinical | China | 24 Aug 2022 |